This inventor holds 1 USPTO granted patent. Top assignee: Debiopharm S.a.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Thomas Rückle: Innovator in Pharmaceutical Science
Introduction
Thomas Rückle is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of pharmaceutical science, particularly in the development of novel compounds with enhanced therapeutic profiles. His work has the potential to impact the treatment of various medical conditions.
Latest Patents
Rückle holds a patent for a novel cyclosporin with an improved activity profile. This invention relates to the pharmaceutical use of this new cyclosporin and includes a pharmaceutical composition containing it. His innovative approach aims to enhance the efficacy of existing treatments.
Career Highlights
Currently, Thomas Rückle is associated with Debiopharm S.A., a company known for its commitment to advancing pharmaceutical research and development. His role at Debiopharm allows him to leverage his expertise in drug formulation and development.
Collaborations
Throughout his career, Rückle has collaborated with esteemed colleagues, including Roland M. Wenger and Manfred Mutter. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thomas Rückle's contributions to pharmaceutical science, particularly through his patent on cyclosporin, highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile